Oxford Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Oxford Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $3.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Oxford Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $3.0M Trade | TransData Nexus

Oxford Laboratories Private Limited

Indian Pharmaceutical Exporter · Antifungals Specialist · $3.0M Total Trade · DGFT Verified

Oxford Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $3.0M across 4 products in 4 therapeutic categories. Based on 114 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Clotrimazole ($1.2M), Gentamicin ($1.1M), Pyrantel ($539.4K).

Oxford Laboratories Private Limited — Export Portfolio & Destination Treemap

Oxford Laboratories Private Limited pharmaceutical export portfolio — 4 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Oxford Laboratories Private Limited? — Company Overview & Market Position

Oxford Laboratories Private Limited, established on January 31, 2000, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH2000PTC123927. As of the latest available data, Oxford Laboratories has an authorized capital of ₹2.50 crore and a paid-up capital of ₹1.50 crore. The company employs approximately 89 professionals across various functions.

Oxford Laboratories specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio spans multiple therapeutic categories, with a significant focus on antifungals, antibiotics, and antimalarial & antiparasitic agents. In the fiscal year ending March 31, 2024, Oxford Laboratories reported a substantial 18.9% increase in revenue and a 39.62% rise in profit, indicating robust financial health and operational efficiency.

What Does Oxford Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Clotrimazole$1.2M

Product Portfolio — Top 4 by Export Value

Oxford Laboratories Private Limited exports 4 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Clotrimazole	Antifungals	$1.2M	42	1.3%	14
2	Gentamicin	Antibiotics	$1.1M	34	2.2%	9
3	Pyrantel	Antimalarial & Antiparasitic	$539.4K	27	16.5%	3
4	Omega	Nutritional Supplements	$134.0K	11	0.7%	10

Oxford Laboratories Private Limited exports 4 pharmaceutical products across 4 therapeutic categories with a total export value of $3.0M. The top category is Antifungals (41.1% of portfolio), followed by Antibiotics (36.6%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Oxford Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Oxford Laboratories operates a state-of-the-art manufacturing plant located in Pardi, Gujarat. This facility is equipped to produce a diverse range of pharmaceutical formulations, including tablets, capsules, external preparations (creams, ointments, gels), liquid orals, injections (both small volume parenterals and large volume parenterals), nutraceuticals, and herbal Ayurvedic and cosmetic products. The plant adheres to stringent quality control measures and is accredited with WHO-GMP and ISO 9001:2015 certifications, underscoring its commitment to producing high-quality pharmaceutical products.

3Key Leadership

The leadership team at Oxford Laboratories comprises individuals with extensive experience in the pharmaceutical industry. The company's directors include Andrei Nikolaevich Medunitsyn and Satyajeet Sumant Khanolkar, both appointed on January 31, 2000. Their strategic vision and management acumen have been instrumental in steering the company towards significant growth and market expansion.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Oxford Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Oxford Laboratories has established a strong presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Gujarat is WHO-GMP certified, which is a prerequisite for exporting pharmaceutical products to these markets. While specific regulatory approvals for each country are not detailed in the available sources, the WHO-GMP certification indicates compliance with international manufacturing standards, facilitating market access in these regions.

2Emerging Markets

Oxford Laboratories has strategically expanded its footprint in emerging markets across Africa, Latin America, and Southeast Asia. The company's products are promoted through its own marketing and sales setup in Russia, most of the CIS, and African countries, where they collaborate with marketing agencies to enhance market penetration. This approach has enabled Oxford Laboratories to establish a robust presence in these regions, catering to the growing demand for quality pharmaceutical products.

3Geographic Strategy

Oxford Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Oxford Laboratories' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's WHO-GMP certification suggests adherence to international manufacturing standards, which is a critical component for FDA approvals. To obtain precise information on FDA approvals and inspections, direct communication with the company or the FDA would be necessary.

2WHO & EU GMP

Oxford Laboratories' manufacturing facility in Gujarat holds WHO-GMP certification, indicating compliance with the World Health Organization's Good Manufacturing Practices. This certification is essential for exporting pharmaceutical products to various international markets, including the European Union. While specific EU GMP certificates or EDQM status are not detailed in the available sources, the WHO-GMP certification serves as a foundational requirement for market access in the EU.

3CDSCO & Indian Regulatory

Oxford Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Oxford Laboratories operates in a competitive pharmaceutical market, with key competitors in overlapping categories such as antifungals, antibiotics, and antimalarial & antiparasitic agents. While specific market share comparisons are not detailed in the available sources, the company's focus on quality manufacturing and strategic market expansion positions it favorably against competitors. The company's diversified product portfolio and adherence to international standards provide a competitive edge in both regulated and emerging markets.

2Key Differentiators

Oxford Laboratories' commitment to quality is demonstrated through its WHO-GMP and ISO 9001:2015 certifications, ensuring adherence to international manufacturing standards. The company's diversified product portfolio, including tablets, capsules, external preparations, liquid orals, injections, nutraceuticals, and herbal Ayurvedic and cosmetic products, caters to a wide range of therapeutic needs. Additionally, Oxford Laboratories' strategic presence in both regulated and emerging markets enhances its global reach and market adaptability.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Oxford Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Oxford Laboratories has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $3.0 million USD and 114 shipments across four therapeutic categories. The company's portfolio concentration, with the top five products accounting for 100% of exports, indicates a focused approach to product development and market strategy. The company's adherence to WHO-GMP and ISO 9001:2015 standards further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirms adherence to the World Health Organization's Good Manufacturing Practices. Verification can be done by contacting the company directly or through the WHO's official channels.

ISO 9001:2015 Certification: Indicates compliance with international quality management standards. Verification can be conducted by contacting the company or through the International Organization for Standardization's official website.

Frequently Asked Questions — Oxford Laboratories Private Limited

How many pharmaceutical products does Oxford Laboratories Private Limited export from India?

Oxford Laboratories Private Limited exports 4 pharmaceutical products across 4 therapeutic categories. The top exports are Clotrimazole ($1.2M), Gentamicin ($1.1M), Pyrantel ($539.4K), Omega ($134.0K). Total export value is $3.0M.

What is Oxford Laboratories Private Limited's total pharmaceutical export value?

Oxford Laboratories Private Limited's total pharmaceutical export value is $3.0M, based on 114 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Oxford Laboratories Private Limited cover?

Oxford Laboratories Private Limited exports across 4 therapeutic categories. The largest are Antifungals (41.1%, 1 products), Antibiotics (36.6%, 1 products), Antimalarial & Antiparasitic (17.9%, 1 products).

Get Full Oxford Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.